Corbus Pharmaceuticals Holdings, Inc. (CRBP) Social Stream
CORBUS PHARMACEUTICALS HOLDINGS INC (CRBP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRBP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-15 | 4 | $3 | $1.4 | $2.063 | $6.13 | -66.35% |
| 2021-11-15 | 3 | $3 | $1.4 | $2.2 | $6.13 | -64.11% |
| 2022-11-09 | 3 | $3 | $3 | $3 | $6.13 | -51.06% |
| 2023-02-13 | 2 | $120.12 | $120.12 | $120.12 | $6.13 | 1859.54% |
| 2023-03-08 | 3 | $120.12 | $3 | $61.56 | $6.13 | 904.24% |
| 2023-05-10 | 2 | $120.12 | $22 | $71.06 | $6.13 | 1059.22% |
| 2023-10-19 | 1 | $120.12 | $22 | $71.06 | $6.13 | 1059.22% |
| 2023-11-07 | 2 | $120.12 | $20 | $70.06 | $6.13 | 1042.9% |
The Trend in the Analyst Price Target
Over the past 52 weeks, CRBP's average price target has gone down $20.03.
CRBP reports an average of 21,053.82% for its upside potential over the past 38 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-13 | 3 | 120.12 | 120.12 | 120.120 | 0.142 | 84491.55% |
| 2023-02-13 | 3 | 120.12 | 120.12 | 120.120 | 4.269 | 2713.77% |
| 2023-02-13 | 3 | 120.12 | 90.09 | 105.105 | 4.269 | 2362.05% |
| 2023-05-10 | 2 | 120.12 | 22.00 | 71.060 | 9.310 | 663.27% |
| 2023-10-19 | 1 | 120.12 | 22.00 | 71.060 | 6.020 | 1080.4% |
CRBP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 18 months, CRBP's average broker recommendation rating improved by 1.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRBP as an investment opportunity.
- CORBUS PHARMACEUTICALS HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 783.74% of all US stocks.
- In terms of how CORBUS PHARMACEUTICALS HOLDINGS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 68.95% of that group.
- In terms of how CORBUS PHARMACEUTICALS HOLDINGS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 790.34% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, CORBUS PHARMACEUTICALS HOLDINGS INC's variance in analysts' estimates is lower than -713.76% of them.
Stocks similar to CORBUS PHARMACEUTICALS HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NERV, SLRX, and ARAV.
View All Top Stocks by Price Target
Is CRBP a Buy, Hold or Sell? See the POWR Ratings now!